Terns Pharmaceuticals (TERN) Consolidated Net Income (2020 - 2023)
Historic Consolidated Net Income for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to -$21.1 million.
- Terns Pharmaceuticals' Consolidated Net Income fell 3127.45% to -$21.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$90.3 million, marking a year-over-year decrease of 4900.8%. This contributed to the annual value of -$89.6 million for FY2024, which is 78.76% up from last year.
- Terns Pharmaceuticals' Consolidated Net Income amounted to -$21.1 million in Q4 2023, which was down 3127.45% from -$29.8 million recorded in Q3 2023.
- Terns Pharmaceuticals' 5-year Consolidated Net Income high stood at -$9.2 million for Q1 2020, and its period low was -$29.8 million during Q3 2023.
- In the last 4 years, Terns Pharmaceuticals' Consolidated Net Income had a median value of -$13.9 million in 2022 and averaged -$15.2 million.
- Per our database at Business Quant, Terns Pharmaceuticals' Consolidated Net Income tumbled by 210.51% in 2021 and then crashed by 7697.38% in 2023.
- Quarter analysis of 4 years shows Terns Pharmaceuticals' Consolidated Net Income stood at -$11.1 million in 2020, then fell by 29.0% to -$14.3 million in 2021, then decreased by 12.07% to -$16.1 million in 2022, then crashed by 31.27% to -$21.1 million in 2023.
- Its Consolidated Net Income was -$21.1 million in Q4 2023, compared to -$29.8 million in Q3 2023 and -$17.9 million in Q2 2023.